Literature DB >> 3062040

Evaluation of five commercial kits to detect dsDNA antibodies.

S A McMillan1, A C Fay.   

Abstract

Experiments were performed to evaluate five commercial kit assays used for the detection of antibodies to dsDNA. The kits were compared using a performance index score as recommended by the guidelines of the European Committee for Clinical Laboratory Standards. The highest performance score was obtained using the radioimmunoassay from Immunodiagnostic Services Ltd, with the Amersham kit second, the immunofluorescence test using Crithidia luciliae third, the Walker ELISA kit fourth, and the haemagglutination assay fifth. The results showed that none of the kits was outstanding, each appeared to detect a different anti-DNA antibody type as different results were obtained using each kit in assays of quality control sera, linearity of the method, antibody detection in various patient groups, and interference by various substances. It is suggested that laboratories using commercial assay kits for the detection of antibodies to dsDNA should decide which is the most appropriate to their particular needs and that a performance index scoring system may be useful in the comparison of assay evaluations between different laboratories.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3062040      PMCID: PMC1141735          DOI: 10.1136/jcp.41.11.1223

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

2.  Stability of DNA/anti-DNA complexes. II. Salt lability and avidity.

Authors:  R L Riley; D J Addis; R P Taylor
Journal:  J Immunol       Date:  1980-01       Impact factor: 5.422

3.  A comparison of three anti-double stranded DNA antibody assays on sera from SLE and other diseases.

Authors:  M C Clarke; R Carr; N M Burdash; Z Y Chen; S K Ainsworth
Journal:  Diagn Immunol       Date:  1986

4.  Anti-DNA antibodies: problems in their study and interpretation.

Authors:  D Eilat
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

5.  Measurement of anti-DNA antibodies: a reappraisal using five different methods.

Authors:  D A Isenberg; C Dudeney; W Williams; I Addison; S Charles; J Clarke; A Todd-Pokropek
Journal:  Ann Rheum Dis       Date:  1987-06       Impact factor: 19.103

6.  Enzyme immunoassay for antibodies to native DNA. Specificity and quality of antibodies.

Authors:  R B Eaton; G Schnneider; P H Schur
Journal:  Arthritis Rheum       Date:  1983-01

7.  A longitudinal study of high and low avidity antibodies to double-stranded DNA in systemic lupus erythematosus.

Authors:  H McGrath; J J Biundo
Journal:  Arthritis Rheum       Date:  1985-04

8.  Complement-fixing antibodies to dsDNA detected by the immunofluorescence technique on Crithidia luciliae. A critical appraisal.

Authors:  R H Esparza; T Swaak; L Aarden; R Smeenk
Journal:  J Rheumatol       Date:  1985-12       Impact factor: 4.666

  8 in total
  1 in total

1.  Lack of specificity for antibodies to double stranded DNA found in four commercial kits.

Authors:  M Kadlubowski; M Jackson; P L Yap; G Neill
Journal:  J Clin Pathol       Date:  1991-03       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.